Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.

about

Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.

P2860

Q51418643-D6708ECB-0A70-4166-B3C2-37B785812E97

P2860

Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.

Item

http://www.wikidata.org/entity/Q36665034

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@ast

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@en

type

Item

label

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@ast

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@en

prefLabel

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@ast

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@en

P1476

Differential Protein Expressio ...... e Tumors and Liver Metastases.

@en

P2093

Daguang Wang

http://www.w3.org/2001/XMLSchema#string

David Zhang

http://www.w3.org/2001/XMLSchema#string

Fei Ye

http://www.w3.org/2001/XMLSchema#string

Miao Cui

http://www.w3.org/2001/XMLSchema#string

Michail Shafir

http://www.w3.org/2001/XMLSchema#string

Michelle Kang Kim

http://www.w3.org/2001/XMLSchema#string

Myron Schwartz

http://www.w3.org/2001/XMLSchema#string

Richard R P Warner

http://www.w3.org/2001/XMLSchema#string

Sasan Roayaie

http://www.w3.org/2001/XMLSchema#string

Stephen C Ward

http://www.w3.org/2001/XMLSchema#string

P2860

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions

Protein signature for non-small cell lung cancer prognosis.

p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.

CDC25 phosphatases in cancer cells: key players? Good targets?

P304

528-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0000000000000459

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26474427

http://www.w3.org/2001/XMLSchema#string

P932

4783230

http://www.w3.org/2001/XMLSchema#string

Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.

about

P2860

P2860

Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932